University of Wisconsin, Madison
1,349
160
223
889
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.2%
165 terminated/withdrawn out of 1349 trials
84.3%
-2.2% vs industry average
10%
129 trials in Phase 3/4
40%
359 of 889 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1349)
Dairy Choline Bioavailability
Role: lead
Neuro-MoD: Neuroplasticity With Motor Development
Role: lead
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Role: lead
Vowel Space Expansion Sensorimotor Adaptation
Role: lead
Standardizing Swallow Pressure Measurements
Role: lead
Mental Health App for Cancer Survivors Study
Role: lead
CBT+ for Depression
Role: lead
Brain Blood Flow and Cerebral Autoregulation Monitoring in Critically Ill Children
Role: lead
Health Engagement & Access Through Learning, Training, and Health-coaching With People With Intellectual and/or Developmental Disabilities
Role: lead
Celecoxib for ENT Pain Management
Role: lead
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Role: lead
Testing and Evaluating an Interactive Media Use Journal for Adolescents
Role: lead
The ENHANCE Study: taVNS and Psilocybin
Role: lead
Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration
Role: lead
The AHA Oneida Study
Role: lead
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Role: lead
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
Role: collaborator
PCOS and Brain Health
Role: lead
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Role: collaborator
Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome
Role: lead